RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.

MLA

Charnalia, Mayuri, et al. “RECIST 1.1 versus Clinico-Radiological Response Assessment for Locally Advanced Cervical Cancer: Implications on Interpreting Survival Outcomes of Future Trials.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 34, no. 6, June 2024, pp. 817–23. EBSCOhost, https://doi.org/10.1136/ijgc-2024-005336.

APA

Charnalia, M., Chopra, S., Mulani, J., Popat, P., Rath, S., Thomeer, M., Mittal, P., Gupta, A., Boere, I., Gupta, S., & Nout, R. A. (2024). RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 34(6), 817–823. https://doi.org/10.1136/ijgc-2024-005336

Chicago

Charnalia, Mayuri, Supriya Chopra, Jaahid Mulani, Palak Popat, Sushmita Rath, Maarten Thomeer, Prachi Mittal, et al. 2024. “RECIST 1.1 versus Clinico-Radiological Response Assessment for Locally Advanced Cervical Cancer: Implications on Interpreting Survival Outcomes of Future Trials.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 34 (6): 817–23. doi:10.1136/ijgc-2024-005336.